---
schema_version: "secwatch.filing_event.v1"
accession: "0000785161-24-000034"
form_type: "8-K"
ticker: "EHC"
cik: "0000785161"
company_name: "Encompass Health Corp"
filed_at: "2024-05-29T23:59:59+00:00"
generated_at: "2026-06-01T07:50:25.443197+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Encompass Health reaffirms FY2024 guidance: revenue $5.25B-$5.325B, Adj. EBITDA $1.03B-$1.065B, Adj. EPS $3.86-$4.11

## Summary
- Reiterated full-year 2024 net operating revenue guidance of $5,250M to $5,325M.
- Reaffirmed Adjusted EBITDA guidance of $1,030M to $1,065M for 2024.
- Adjusted diluted EPS from continuing ops expected between $3.86 and $4.11.
- Fireside chat at Leerink Partners Healthcare Crossroads Conference on May 30, 2024.

## SEC filing metadata
- accession: 0000785161-24-000034
- form_type: 8-K
- ticker: EHC
- cik: 0000785161
- company_name: Encompass Health Corp
- filed_at: 2024-05-29T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/785161/000078516124000034/0000785161-24-000034-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/785161/000078516124000034/ehc-20240529.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000785161-24-000034
- JSON: https://secwatch.observer/filing/0000785161-24-000034.json
- Plain text: https://secwatch.observer/filing/0000785161-24-000034.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.